Literature DB >> 29580848

Human biomonitoring reference values for some non-persistent chemicals in blood and urine derived from the Canadian Health Measures Survey 2009-2013.

Cheryl Khoury1, Kate Werry2, Douglas Haines2, Mike Walker2, Morie Malowany2.   

Abstract

The Canadian Health Measures Survey collects nationally representative human biomonitoring data on a suite of chemicals and their metabolites, including many non-persistent chemicals. Data has been collected on non-persistent chemicals, including acrylamide, chlorophenols, environmental phenols and triclocarban, organophosphate insecticides, phthalates, polycyclic aromatic hydrocarbon, pyrethroid insecticides, and volatile organic compounds from 2009 to 2013. Using a systematic approach building on the reference interval concept proposed by the International Federation of Clinical Chemistry and Laboratory Medicine and the International Union of Pure and Applied Chemistry, we derive human biomonitoring reference values (RV95s) for these classes of non-persistent chemicals in blood and urine for the general Canadian population. RV95s were derived for biomarkers of non-persistent chemicals with widespread detection in Canadians (>66% detection rate). Samples with urinary creatinine levels outside the recommended range of 0.3-3.0 μg/L were excluded. Reference populations were constructed by applying smoking and fasting as exclusion criteria where appropriate. Age and sex were evaluated as possible partitioning criteria and separate RV95s were derived for sub-populations in cases where partitioning was deemed necessary. Reference values were derived for 40 biomarkers and represent the first set of RV95s for non-persistent chemicals in the general Canadian population. These values provide a measure of the upper margin of background exposure in the general population and can be compared against individual and population human biomonitoring data. RV95s can be used to by public health officials to identify individuals with high exposures, and by risk assessors and risk managers to identify atypical exposures or subpopulations with elevated exposures. Crown
Copyright © 2018. Published by Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Canadian Health Measures Survey; Human biomonitoring; Non-persistent organic pollutants; Reference values

Mesh:

Substances:

Year:  2018        PMID: 29580848     DOI: 10.1016/j.ijheh.2018.03.003

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  4 in total

1.  Simultaneous quantification of pyrethroid metabolites in urine of non-toilet-trained children in Japan.

Authors:  Jun Ueyama; Yuki Ito; Risa Hamada; Naoko Oya; Sayaka Kato; Taro Matsuki; Hazuki Tamada; Kayo Kaneko; Shinji Saitoh; Mayumi Sugiura-Ogasawara; Takeshi Ebara; Michihiro Kamijima
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

2.  Exposure assessment of children living in homes with hookah smoking parents to polycyclic aromatic hydrocarbons: urinary level, exposure predictors, and risk assessment.

Authors:  Zeynab Tabatabaei; Narges Shamsedini; Amin Mohammadpour; Mohammad Ali Baghapour; Mohammad Hoseini
Journal:  Environ Sci Pollut Res Int       Date:  2022-05-11       Impact factor: 5.190

3.  Study Design, Rationale and Procedures for Human Biomonitoring of Hazardous Chemicals from Foods and Cooking in Korea.

Authors:  Seokwon Lee; Ryoung Me Ahn; Jae Hyoun Kim; Yoon-Deok Han; Jin Heon Lee; Bu-Soon Son; Kyoungho Lee
Journal:  Int J Environ Res Public Health       Date:  2019-07-19       Impact factor: 3.390

4.  Development of a strategic approach for comprehensive detection of organophosphate pesticide metabolites in urine: Extrapolation of cadusafos and prothiofos metabolomics data of mice to humans.

Authors:  Karin Nomasa; Naoko Oya; Yuki Ito; Takehito Terajima; Takahiro Nishino; Nayan Chandra Mohanto; Hirotaka Sato; Motohiro Tomizawa; Michihiro Kamijima
Journal:  J Occup Health       Date:  2021-01       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.